Jin Medical International Ltd. (ZJYL) P/E Ratio History
Deep ValueTrading at 12.7x · 17th percentile of 5-year range · Significant discount to historical valuation · Data 2023–2025
Loading P/E history...
P/E Ratio Analysis
As of July 8, 2026, Jin Medical International Ltd. (ZJYL) trades at a price-to-earnings ratio of 12.7x, with a stock price of $1.91 and trailing twelve-month earnings per share of $0.62.
The current P/E is 67% below its 5-year average of 39.0x. Over the past five years, ZJYL's P/E has ranged from a low of 10.9x to a high of 90.4x, placing the current valuation at the 17th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.4x, ZJYL trades at a 45% discount to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 198.8x.
The PEG ratio of 1.99 (P/E divided by -68% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, ZJYL trades at a notable discount to the S&P 500 median P/E of 25.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ZJYL DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ZJYL Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ZJYL P/E vs Peers
Rehabilitation and mobility aids peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $63B | 99.8 | 3.38 | -65% | |
| $2B | 6.7Lowest | 0.65Best | +817%Best | |
| $2B | 41.9 | 2.17 | +31% | |
| $108B | 22.5 | 3.21 | +3% | |
| $120B | 37.3 | 2.51 | +8% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
ZJYL Historical P/E Data (2023–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | - | $11.30 | $0.62 | 18.3x | -53% |
| FY2025 Q2 | Mar 30 2025 | $14.05 | $0.60 | 23.5x | -40% |
| FY2024 Q4 | Sep 30 2024 | $53.80 | $0.87 | 61.8x | +58% |
| FY2024 Q2 | Mar 30 2024 | $76.80 | $0.85 | 90.4x | +132% |
| FY2023 Q4 | Sep 30 2023 | $23.40 | $0.80 | 29.2x | -25% |
| FY2023 Q2 | - | $7.65 | $0.70 | 10.9x | -72% |
Average P/E for displayed period: 39.0x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ZJYL — Frequently Asked Questions
Quick answers to the most common questions about buying ZJYL stock.
What is ZJYL's P/E ratio?
Jin Medical International Ltd. (ZJYL) trailing twelve-month P/E ratio is 12.7x, based on TTM diluted EPS of $0.62. The 5-year average P/E is 39.0x and the historical range spans 10.9x to 90.4x.
Is ZJYL stock overvalued or undervalued?
ZJYL trades at 12.7x P/E, below its 5-year average of 39.0x. At the 17th percentile of its historical range (10.9x–90.4x), the stock is priced at a discount to its own history.
Is ZJYL stock expensive?
No, ZJYL is not expensive on a historical basis. The current P/E of 12.7x is below the 5-year average of 39.0x and sits at the 17th percentile of its valuation range.
What is ZJYL's historical P/E range?
Over the past 5 years, ZJYL's P/E ratio has ranged from 10.9x to 90.4x, with a median of 29.2x and an average of 39.0x. The current P/E of 12.7x places the stock at the 17th percentile of this range. Full historical data spans 2023–2025.
How does ZJYL's P/E compare to the S&P 500?
ZJYL trades at 12.7x P/E versus the S&P 500 median of 25.9x. The 51% discount to the market suggests lower growth expectations or perceived higher risk.
How does ZJYL's valuation compare to Healthcare peers?
Jin Medical International Ltd. P/E of 12.7x compares to the Healthcare sector median of 23.4x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is ZJYL's PEG ratio?
ZJYL PEG ratio is 1.99, based on a P/E of 12.7x and EPS growth of -68.1%. A PEG between 1 and 2 suggests valuation aligns with growth expectations — typically considered fair.
What is ZJYL's earnings yield?
ZJYL earnings yield is 7.85%, the inverse of its 12.7x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.